Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-047640

Chief Financial Officer sold 10,000 shares at $40.00 ($400,000)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-08-17 Option exercise +10,000 $6.32 $63,200 11,000 D
Cohen Chad M Chief Financial Officer 2020-08-17 Sale −10,000 $40.00 $400,000 1,000 D
Derivatives
Cohen Chad M Chief Financial Officer 2020-08-17 Option exercise · Stock Option (Right To Buy) −10,000 610,000 D
Open-market sales · 10,000 sh · avg $40.00 · $400,000
Loading xslF345X03/doc4.xml…